Abstract
This article aims to analyse the first-time emergence of African swine fever (ASF) in Mizoram. We collated the outbreak data and identified the time and locations of ASF emergence. To understand the impact of the outbreak, we have calculated the morbidity rate, mortality rate, case fatality rate (CFR) and overall pig depopulation rate. We identified that ASF emerged in total 178 locations in all 11 districts of Mizoram between March-July 2021, after a peak in June, and the disease continued to spread till the end of 2021 before re-emergence in March 2022. The overall morbidity rate and mortality rate of ASF between March-July 2021 in Mizoram were estimated to be 33.8% and 31.1%, while the average morbidity rate and the mortality rate of 10 districts were found to be 29.5% and 27.6% respectively. Overall CFR of ASF between March-July 2021 was estimated to be 92.1% and the average of all 11 districts was found to be 96.1%. Toward the end of 2021, the mortality rate increased by a total of 42.7% change and an average of 25.3% change. We estimated an overall 70% depopulation of susceptible pigs by disease and culling by end of 2021. This report is evidence that ASF has remained catastrophic and, keeping in view the complex nature and history of the virus on genotype adaptability associated with a high propensity for transboundary expansion, the virus continues to be a threat.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was conducted as part of the project titled "Establishment of a Consortium for One Health to address Zoonotic and Transboundary Diseases in India, including the Northeast Region" approved by the Department of Biotechnology, Govt. of India with Order No: BT/PR39032/ADV/90/285/2020 dated 06/08/2021
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was conducted as part of the project titled “Establishment of a Consortium for One Health to address Zoonotic and Transboundary Diseases in India, including the Northeast Region” approved by the Department of Biotechnology, Govt. of India with Order No: BT/PR39032/ADV/90/285/2020 dated 06/08/2021.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
